Currently, immunotherapy for PC only shows the inhibition of immune checkpoints such as CTLA4, PD1 and PDL1, but the efficacy is average, thus, PC is also referred to as an immune cold tumour. This evidence concerns the gene CD274 and pachyonychia congenita.